{
  "id": "4e400a90490b010d",
  "title": "Next gen cancer drug shows surprising anti aging power",
  "description": "A next-generation drug tested in yeast was found to extend lifespan and slow aging by influencing a major growth-control pathway. Researchers also uncovered an unexpected role for agmatinases, enzymes that help keep this pathway in balance. Diet and gut micro\u2026",
  "content": "Researchers at Queen Mary University of London's School of Biological and Behavioural Sciences have demonstrated that the experimental TOR inhibitor rapalink-1 can extend the chronological lifespan o\u2026 [+2975 chars]",
  "source": "Science Daily",
  "source_url": "https://www.sciencedaily.com/releases/2025/12/251205054729.htm",
  "published_at": "2025-12-05T14:39:16Z",
  "fetched_at": "2025-12-06T18:33:06.472112+00:00",
  "category": "demographics_migration",
  "subcategory": null,
  "keywords": [
    "drug",
    "aging",
    "search:longevity aging research"
  ],
  "location": null,
  "raw_data": {
    "source": {
      "id": null,
      "name": "Science Daily"
    },
    "author": null,
    "title": "Next gen cancer drug shows surprising anti aging power",
    "description": "A next-generation drug tested in yeast was found to extend lifespan and slow aging by influencing a major growth-control pathway. Researchers also uncovered an unexpected role for agmatinases, enzymes that help keep this pathway in balance. Diet and gut micro\u2026",
    "url": "https://www.sciencedaily.com/releases/2025/12/251205054729.htm",
    "urlToImage": "https://www.sciencedaily.com/images/1920/anti-aging-beauty-skincare-face.webp",
    "publishedAt": "2025-12-05T14:39:16Z",
    "content": "Researchers at Queen Mary University of London's School of Biological and Behavioural Sciences have demonstrated that the experimental TOR inhibitor rapalink-1 can extend the chronological lifespan o\u2026 [+2975 chars]"
  }
}